2022 Annual Meeting | Hot Topics Plenary Session

Date Saturday 04/02/22

Time 05:00 PM - 06:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) James N. Goldenberg, MD, FAAN

Topic(s) General Neurology

Learning Objectives This session features the latest, cutting-edge translational research related to clinical issues of importance. Three outstanding speakers provide summaries of their recent research findings and describe the clinical implications of the results.

CME Available 1.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:00 PM - 05:17 PM PDT	Speaker	Therapeutically Targeting Senescent Cells to Treat Age-related Diseases Miranda E. Orr, PhD
05:17 PM - 05:34 PM PDT	Speaker	Viruses and Neurological Autoimmunity Michael R. Wilson, MD, FAAN
05:34 PM - 05:51 PM PDT	Speaker	Glymphatic System Dysfunction: A Unifying Feature in Neurodegeneration Humberto Mestre, MD, PhD

Faculty Disclosures
James N. Goldenberg, MD, FAAN	Dr. Goldenberg has received personal compensation for serving as an employee of JEM Headlands Research. Dr. Goldenberg has received personal compensation for serving as an employee of Headlands Research. Dr. Goldenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NIRA Medical Group. Dr. Goldenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Palm Beach County Medical Society. Dr. Goldenberg has stock in Headlands Research.
Miranda E. Orr, PhD	The institution of Miranda E. Orr, PhD has received research support from NIH. The institution of Miranda E. Orr, PhD has received research support from United States Department of Veterans Affairs. The institution of Miranda E. Orr, PhD has received research support from Alzheimer's Drug Discovery Foundation. The institution of Miranda E. Orr, PhD has received research support from Cure Alzheimer's Fund. The institution of Miranda E. Orr, PhD has received research support from Charleston Conference on Alzheimer's Disease. The institution of Miranda E. Orr, PhD has received research support from Older Americans Independence Center. Miranda E. Orr, PhD has received intellectual property interests from a discovery or technology relating to health care.
Michael R. Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Humberto Mestre, MD, PhD	Dr. Mestre has received intellectual property interests from a discovery or technology relating to health care.